A
Anavex Life Sciences Corp D
D
AVXL
7.51000
USD
-0.17
(-2.15%)
مغلق
حجم التداول
21,559
الربح لكل سهم
-1
العائد الربحي
-
P/E
-13
حجم السوق
641,142,609
الأخبار المقالات
العنوان: Anavex Life Sciences Corp
القطاع: Healthcare
الصناعة: Biotechnology
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.